{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT02561767",
      "OrgStudyIdInfo": {
        "OrgStudyId": "MSCs-KTx-DCD-150924"
      },
      "Organization": {
        "OrgFullName": "First Affiliated Hospital, Sun Yat-Sen University",
        "OrgClass": "OTHER"
      },
      "BriefTitle": "Effect of BM-MSCs in DCD Kidney Transplantation",
      "OfficialTitle": "The Efficacy and Safety of Bone Marrow-derived Mesenchymal Stem Cells in Kidney Transplantation From Chinese Donation After Citizen Death (DCD): A Multi-center Randomized Controlled Trial"
    },
    "StatusModule": {
      "StatusVerifiedDate": "September 2015",
      "OverallStatus": "Unknown status",
      "LastKnownStatus": "Not yet recruiting",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "October 2015"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "October 2016",
        "PrimaryCompletionDateType": "Anticipated"
      },
      "CompletionDateStruct": {
        "CompletionDate": "October 2017",
        "CompletionDateType": "Anticipated"
      },
      "StudyFirstSubmitDate": "September 25, 2015",
      "StudyFirstSubmitQCDate": "September 25, 2015",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "September 28, 2015",
        "StudyFirstPostDateType": "Estimate"
      },
      "LastUpdateSubmitDate": "September 25, 2015",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "September 28, 2015",
        "LastUpdatePostDateType": "Estimate"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Principal Investigator",
        "ResponsiblePartyInvestigatorFullName": "Changxi Wang",
        "ResponsiblePartyInvestigatorTitle": "Director of Organ Transplant Center",
        "ResponsiblePartyInvestigatorAffiliation": "First Affiliated Hospital, Sun Yat-Sen University"
      },
      "LeadSponsor": {
        "LeadSponsorName": "First Affiliated Hospital, Sun Yat-Sen University",
        "LeadSponsorClass": "OTHER"
      },
      "CollaboratorList": {
        "Collaborator": [
          {
            "CollaboratorName": "Second Affiliated Hospital of Guangzhou Medical University",
            "CollaboratorClass": "OTHER"
          }
        ]
      }
    },
    "OversightModule": {
      "OversightHasDMC": "No"
    },
    "DescriptionModule": {
      "BriefSummary": "This study is designed to determine the efficacy and safety of allogeneic bone marrow-derived mesenchymal stem cells in kidney transplantation from Chinese donation after citizen's death (DCD). A pair uremia patients receiving kidney grafts from a same donor are randomized into two groups: MSCs group and control group. Besides routine induction therapy (ATG or Basiliximab) and maintenance immunosuppressive drugs (low-dose Tacrolimus + MPA + prednisone), patients in MSCs group are administered MSCs treatment (1*10^6/kg). Allogeneic bone marrow-derived MSCs (1*10^6/kg) are given intravenously at day 0 (post renal reperfusion during surgery), day 7, day 14 and day 21. The renal allograft function, rejection, patient/graft survival and severe adverse events within 12 months post-transplant are monitored."
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "Kidney Transplantation",
          "Acute Kidney Tubular Necrosis"
        ]
      },
      "KeywordList": {
        "Keyword": [
          "kidney transplantation",
          "mesenchymal stem cell",
          "donation after citizen's death",
          "ischemia reperfusion injury",
          "renal function recovery"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Interventional",
      "PhaseList": {
        "Phase": [
          "Phase 1",
          "Phase 2"
        ]
      },
      "DesignInfo": {
        "DesignAllocation": "Randomized",
        "DesignInterventionModel": "Parallel Assignment",
        "DesignPrimaryPurpose": "Treatment",
        "DesignMaskingInfo": {
          "DesignMasking": "Single",
          "DesignWhoMaskedList": {
            "DesignWhoMasked": [
              "Participant"
            ]
          }
        }
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "120",
        "EnrollmentType": "Anticipated"
      }
    },
    "ArmsInterventionsModule": {
      "ArmGroupList": {
        "ArmGroup": [
          {
            "ArmGroupLabel": "MSCs group",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "Allogeneic bone marrow-derived mesenchymal stem cells (10^6/kg) from third party donors is intravenously given at day 0 (after renal artery reperfusion), day 7, day 14 and day 21.Induction therapy: ATG or Basiliximab; Maintenance therapy: low-dose Tacrolimus + mycophenolic acid + prednisone.\n\nThe third-party MSCs have no similar HLA alleles of kidney donors, and have no HLA alleles specific to preformed anti-HLA antibodies in recipients prior to KTx.",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Other: bone marrow-derived mesenchymal stem cells",
                "Drug: Induction therapy (ATG or Basiliximab)",
                "Drug: Maintenance therapy (Low-dose CNI + MPA + steroids)"
              ]
            }
          },
          {
            "ArmGroupLabel": "Control group",
            "ArmGroupType": "Placebo Comparator",
            "ArmGroupDescription": "Placebo (saline) is intravenously given at day 0 (after renal artery reperfusion), day 7, day 14 and day 21. Induction therapy: ATG or Basiliximab; Maintenance therapy: low-dose Tacrolimus + mycophenolic acid + prednisone.",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Other: Saline",
                "Drug: Induction therapy (ATG or Basiliximab)",
                "Drug: Maintenance therapy (Low-dose CNI + MPA + steroids)"
              ]
            }
          }
        ]
      },
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Other",
            "InterventionName": "bone marrow-derived mesenchymal stem cells",
            "InterventionDescription": "BM-MSCs is harvested from third-party health volunteer donors.",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "MSCs group"
              ]
            },
            "InterventionOtherNameList": {
              "InterventionOtherName": [
                "BM-MSCs"
              ]
            }
          },
          {
            "InterventionType": "Other",
            "InterventionName": "Saline",
            "InterventionDescription": "Saline as placebo of MSCs",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Control group"
              ]
            }
          },
          {
            "InterventionType": "Drug",
            "InterventionName": "Induction therapy (ATG or Basiliximab)",
            "InterventionDescription": "ATG, antithymocyte globulin; Basiliximab, anti-CD25 mAb. Recipients receive ATG or Basiliximab as induction therapy in both MSCs group and control group.",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Control group",
                "MSCs group"
              ]
            },
            "InterventionOtherNameList": {
              "InterventionOtherName": [
                "ATG or Basiliximab"
              ]
            }
          },
          {
            "InterventionType": "Drug",
            "InterventionName": "Maintenance therapy (Low-dose CNI + MPA + steroids)",
            "InterventionDescription": "Maintenance immunosuppressive therapy consists of low-dose tacrolimus and mycophenolic acid and steroids. Recipients receive the same maintenance therapy in both MSCs group and control group.",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Control group",
                "MSCs group"
              ]
            },
            "InterventionOtherNameList": {
              "InterventionOtherName": [
                "Low-dose tacrolimus + Mycophenolic acid (MPA) + steroids"
              ]
            }
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "Estimated glomerular filtration rate",
            "PrimaryOutcomeDescription": "eGFR at one month post-transplant",
            "PrimaryOutcomeTimeFrame": "1 month"
          }
        ]
      },
      "SecondaryOutcomeList": {
        "SecondaryOutcome": [
          {
            "SecondaryOutcomeMeasure": "Incidence of slow graft function",
            "SecondaryOutcomeTimeFrame": "12 months"
          },
          {
            "SecondaryOutcomeMeasure": "Incidence of delayed graft function",
            "SecondaryOutcomeTimeFrame": "12 months"
          },
          {
            "SecondaryOutcomeMeasure": "Proportion of normal renal function recovery",
            "SecondaryOutcomeTimeFrame": "12 months"
          },
          {
            "SecondaryOutcomeMeasure": "Time to renal function recovery",
            "SecondaryOutcomeTimeFrame": "12 months"
          },
          {
            "SecondaryOutcomeMeasure": "Patient survival",
            "SecondaryOutcomeTimeFrame": "12 months"
          },
          {
            "SecondaryOutcomeMeasure": "Renal graft survival",
            "SecondaryOutcomeTimeFrame": "12 months"
          },
          {
            "SecondaryOutcomeMeasure": "Incidence of acute rejection",
            "SecondaryOutcomeTimeFrame": "12 months"
          },
          {
            "SecondaryOutcomeMeasure": "Severe adverse events",
            "SecondaryOutcomeTimeFrame": "12 months"
          },
          {
            "SecondaryOutcomeMeasure": "Estimated glomerular filtration rate",
            "SecondaryOutcomeDescription": "eGFR up to 12 months post-transplant",
            "SecondaryOutcomeTimeFrame": "12 months"
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Inclusion Criteria:\n\nPrimary kidney transplantation\nReceiving induction therapy and combined immunosuppressive regimens (CNIs + MPA + steroids)\nPatient is willing and capable of giving written informed consent for study participation and able to participate in the study for 12 months\n\nExclusion Criteria:\n\nSecondary kidney transplantation\nCombined or multi-organ transplantation\nWomen who are pregnant, intend to become pregnant in the next 1 years, breastfeeding, or have a positive pregnancy test on enrollment or prior to study medication administration\nPanel reactive antibody (PRA)>20%\nCDC crossmatch is positive\nDonors or recipients are known hepatitis C antibody-positive or polymerase chain reaction (PCR) positive for hepatitis C\nDonors or recipients are known hepatitis B surface antigen-positive or PCR positive for hepatitis B\nDonors or recipients are known human immunodeficiency virus (HIV) infection\nPatients with active infection\nRecipients with a history of substance abuse (drugs or alcohol) within the past 6 months, or psychotic disorders that are not capable with adequate study follow-up.\nPatients with severe cardiovascular dysfunction\nWBC<3*10^9/L or RBC <5g/dL\nHighly allergic constitution or having severe history of allergies.\nPatients with active peptic ulcer disease, chronic diarrhea, or gastrointestinal problem affect absorption\nPatients with a history of cancer within the last 5 years\nPrisoner or patients compulsorily detained (involuntarily incarcerated) for treatment or either a psychiatric or physical (e.g. infectious disease) illness",
      "HealthyVolunteers": "No",
      "Gender": "All",
      "MinimumAge": "18 Years",
      "MaximumAge": "65 Years",
      "StdAgeList": {
        "StdAge": [
          "Adult",
          "Older Adult"
        ]
      }
    },
    "ContactsLocationsModule": {
      "CentralContactList": {
        "CentralContact": [
          {
            "CentralContactName": "Changxi Wang, M.D., Ph.D",
            "CentralContactRole": "Contact",
            "CentralContactPhone": "86-20-87333428",
            "CentralContactEMail": "wangchx@mail.sysu.edu.cn"
          },
          {
            "CentralContactName": "Longshan Liu, M.D., Ph.D",
            "CentralContactRole": "Contact",
            "CentralContactPhone": "86-20-87306082",
            "CentralContactEMail": "liulshan@mail.sysu.edu.cn"
          }
        ]
      },
      "OverallOfficialList": {
        "OverallOfficial": [
          {
            "OverallOfficialName": "Changxi Wang, M.D., Ph.D",
            "OverallOfficialAffiliation": "First Affiliated Hospital, Sun Yat-Sen University",
            "OverallOfficialRole": "Study Chair"
          }
        ]
      },
      "LocationList": {
        "Location": [
          {
            "LocationFacility": "The First Affiliated Hospital, Sun Yat-sen University",
            "LocationCity": "Guangzhou",
            "LocationState": "Guangdong",
            "LocationZip": "510080",
            "LocationCountry": "China"
          }
        ]
      }
    },
    "ReferencesModule": {
      "ReferenceList": {
        "Reference": [
          {
            "ReferencePMID": "23263506",
            "ReferenceType": "background",
            "ReferenceCitation": "Peng Y, Ke M, Xu L, Liu L, Chen X, Xia W, Li X, Chen Z, Ma J, Liao D, Li G, Fang J, Pan G, Xiang AP. Donor-derived mesenchymal stem cells combined with low-dose tacrolimus prevent acute rejection after renal transplantation: a clinical pilot study. Transplantation. 2013 Jan 15;95(1):161-8. doi: 10.1097/TP.0b013e3182754c53. Erratum in: Transplantation. 2014 Mar 27;97(6):e37. Pan, Guanghui [added]."
          }
        ]
      },
      "SeeAlsoLinkList": {
        "SeeAlsoLink": [
          {
            "SeeAlsoLinkLabel": "Previous publication",
            "SeeAlsoLinkURL": "http://www.ncbi.nlm.nih.gov/pubmed/23263506"
          }
        ]
      }
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 20, 2022"
    },
    "ConditionBrowseModule": {
      "ConditionMeshList": {
        "ConditionMesh": [
          {
            "ConditionMeshId": "D000007683",
            "ConditionMeshTerm": "Kidney Tubular Necrosis, Acute"
          },
          {
            "ConditionMeshId": "D000009336",
            "ConditionMeshTerm": "Necrosis"
          }
        ]
      },
      "ConditionAncestorList": {
        "ConditionAncestor": [
          {
            "ConditionAncestorId": "D000010335",
            "ConditionAncestorTerm": "Pathologic Processes"
          },
          {
            "ConditionAncestorId": "D000058186",
            "ConditionAncestorTerm": "Acute Kidney Injury"
          },
          {
            "ConditionAncestorId": "D000051437",
            "ConditionAncestorTerm": "Renal Insufficiency"
          },
          {
            "ConditionAncestorId": "D000007674",
            "ConditionAncestorTerm": "Kidney Diseases"
          },
          {
            "ConditionAncestorId": "D000014570",
            "ConditionAncestorTerm": "Urologic Diseases"
          }
        ]
      },
      "ConditionBrowseLeafList": {
        "ConditionBrowseLeaf": [
          {
            "ConditionBrowseLeafId": "M9695",
            "ConditionBrowseLeafName": "Ischemia",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M17251",
            "ConditionBrowseLeafName": "Reperfusion Injury",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M5997",
            "ConditionBrowseLeafName": "Death",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M11436",
            "ConditionBrowseLeafName": "Necrosis",
            "ConditionBrowseLeafAsFound": "Necrosis",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M9858",
            "ConditionBrowseLeafName": "Kidney Tubular Necrosis, Acute",
            "ConditionBrowseLeafAsFound": "Acute Kidney Tubular Necrosis",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M28151",
            "ConditionBrowseLeafName": "Acute Kidney Injury",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M25871",
            "ConditionBrowseLeafName": "Renal Insufficiency",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M9850",
            "ConditionBrowseLeafName": "Kidney Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M16471",
            "ConditionBrowseLeafName": "Urologic Diseases",
            "ConditionBrowseLeafRelevance": "low"
          }
        ]
      },
      "ConditionBrowseBranchList": {
        "ConditionBrowseBranch": [
          {
            "ConditionBrowseBranchAbbrev": "BC23",
            "ConditionBrowseBranchName": "Symptoms and General Pathology"
          },
          {
            "ConditionBrowseBranchAbbrev": "All",
            "ConditionBrowseBranchName": "All Conditions"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC14",
            "ConditionBrowseBranchName": "Heart and Blood Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "BXS",
            "ConditionBrowseBranchName": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
          }
        ]
      }
    },
    "InterventionBrowseModule": {
      "InterventionMeshList": {
        "InterventionMesh": [
          {
            "InterventionMeshId": "D000009173",
            "InterventionMeshTerm": "Mycophenolic Acid"
          },
          {
            "InterventionMeshId": "D000016559",
            "InterventionMeshTerm": "Tacrolimus"
          },
          {
            "InterventionMeshId": "D000077552",
            "InterventionMeshTerm": "Basiliximab"
          }
        ]
      },
      "InterventionAncestorList": {
        "InterventionAncestor": [
          {
            "InterventionAncestorId": "D000007166",
            "InterventionAncestorTerm": "Immunosuppressive Agents"
          },
          {
            "InterventionAncestorId": "D000007155",
            "InterventionAncestorTerm": "Immunologic Factors"
          },
          {
            "InterventionAncestorId": "D000045505",
            "InterventionAncestorTerm": "Physiological Effects of Drugs"
          },
          {
            "InterventionAncestorId": "D000065095",
            "InterventionAncestorTerm": "Calcineurin Inhibitors"
          },
          {
            "InterventionAncestorId": "D000004791",
            "InterventionAncestorTerm": "Enzyme Inhibitors"
          },
          {
            "InterventionAncestorId": "D000045504",
            "InterventionAncestorTerm": "Molecular Mechanisms of Pharmacological Action"
          },
          {
            "InterventionAncestorId": "D000000903",
            "InterventionAncestorTerm": "Antibiotics, Antineoplastic"
          },
          {
            "InterventionAncestorId": "D000000970",
            "InterventionAncestorTerm": "Antineoplastic Agents"
          },
          {
            "InterventionAncestorId": "D000000904",
            "InterventionAncestorTerm": "Antibiotics, Antitubercular"
          },
          {
            "InterventionAncestorId": "D000000995",
            "InterventionAncestorTerm": "Antitubercular Agents"
          },
          {
            "InterventionAncestorId": "D000000900",
            "InterventionAncestorTerm": "Anti-Bacterial Agents"
          },
          {
            "InterventionAncestorId": "D000000890",
            "InterventionAncestorTerm": "Anti-Infective Agents"
          }
        ]
      },
      "InterventionBrowseLeafList": {
        "InterventionBrowseLeaf": [
          {
            "InterventionBrowseLeafId": "M13273",
            "InterventionBrowseLeafName": "Prednisone",
            "InterventionBrowseLeafRelevance": "low"
          },
          {
            "InterventionBrowseLeafId": "M3377",
            "InterventionBrowseLeafName": "Antibodies",
            "InterventionBrowseLeafRelevance": "low"
          },
          {
            "InterventionBrowseLeafId": "M3431",
            "InterventionBrowseLeafName": "Antilymphocyte Serum",
            "InterventionBrowseLeafRelevance": "low"
          },
          {
            "InterventionBrowseLeafId": "M9336",
            "InterventionBrowseLeafName": "Immunoglobulins",
            "InterventionBrowseLeafRelevance": "low"
          },
          {
            "InterventionBrowseLeafId": "M11280",
            "InterventionBrowseLeafName": "Mycophenolic Acid",
            "InterventionBrowseLeafAsFound": "Amplification",
            "InterventionBrowseLeafRelevance": "high"
          },
          {
            "InterventionBrowseLeafId": "M18102",
            "InterventionBrowseLeafName": "Tacrolimus",
            "InterventionBrowseLeafAsFound": "Coronary",
            "InterventionBrowseLeafRelevance": "high"
          },
          {
            "InterventionBrowseLeafId": "M1830",
            "InterventionBrowseLeafName": "Basiliximab",
            "InterventionBrowseLeafAsFound": "Dietary intervention",
            "InterventionBrowseLeafRelevance": "high"
          },
          {
            "InterventionBrowseLeafId": "M9364",
            "InterventionBrowseLeafName": "Immunosuppressive Agents",
            "InterventionBrowseLeafRelevance": "low"
          },
          {
            "InterventionBrowseLeafId": "M9353",
            "InterventionBrowseLeafName": "Immunologic Factors",
            "InterventionBrowseLeafRelevance": "low"
          },
          {
            "InterventionBrowseLeafId": "M29605",
            "InterventionBrowseLeafName": "Calcineurin Inhibitors",
            "InterventionBrowseLeafRelevance": "low"
          },
          {
            "InterventionBrowseLeafId": "M3374",
            "InterventionBrowseLeafName": "Anti-Bacterial Agents",
            "InterventionBrowseLeafRelevance": "low"
          },
          {
            "InterventionBrowseLeafId": "M3376",
            "InterventionBrowseLeafName": "Antibiotics, Antitubercular",
            "InterventionBrowseLeafRelevance": "low"
          },
          {
            "InterventionBrowseLeafId": "M3463",
            "InterventionBrowseLeafName": "Antitubercular Agents",
            "InterventionBrowseLeafRelevance": "low"
          },
          {
            "InterventionBrowseLeafId": "M3366",
            "InterventionBrowseLeafName": "Anti-Infective Agents",
            "InterventionBrowseLeafRelevance": "low"
          }
        ]
      },
      "InterventionBrowseBranchList": {
        "InterventionBrowseBranch": [
          {
            "InterventionBrowseBranchAbbrev": "Infl",
            "InterventionBrowseBranchName": "Anti-Inflammatory Agents"
          },
          {
            "InterventionBrowseBranchAbbrev": "ANeo",
            "InterventionBrowseBranchName": "Antineoplastic Agents"
          },
          {
            "InterventionBrowseBranchAbbrev": "All",
            "InterventionBrowseBranchName": "All Drugs and Chemicals"
          },
          {
            "InterventionBrowseBranchAbbrev": "Infe",
            "InterventionBrowseBranchName": "Anti-Infective Agents"
          }
        ]
      }
    }
  }
}